The interrelationship between helicobacter pylori vacuolating cytotoxin and gastric carcinoma

American Journal of Gastroenterology

Volumn 93, Issue 10, 1998, Pages 1841-1847

  De Figueiredo Soares, Taciana ^a   Queiroz, Dulciene Maria De Magalhães ^a   Nogueira Mendes, Edilberto ^a   Rocha, Gifone Aguiar ^a   Oliveira, Andréia Maria Rocha ^a   Demas Álvares Cabral, Mônica Maria ^a   De Oliveira, Celso Affonso ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIN; IMMUNOGLOBULIN G; TOXIN ANTIBODY;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; FEMALE; HELA CELL; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; STOMACH CARCINOMA; STOMACH MUCOSA;

ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOBLOTTING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 0345222477     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(98)00414-6     Document Type: Article

References (52)

1. 1. Nogueira AMMF, Ribeiro GM, Rodrigues MAG, et al. Prevalence of Helicobacter pylori in Brazilian patients with gastric carcinoma. Am J Clin Pathol 1993;100:236-9.
2. 2. Forman D. Helicobacter pylori and gastric cancer. Scand J Gastroenterol 1996;31 (suppl 215):48-51.
3. 3. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1:1273-5.
4. 4. Sipponen P. Long-term consequences of gastroduodenal inflammation. Eur J Gastroenterol Hepatol 1992;4 (suppl 2):S25-9.
5. 5. Coelho LGV, Queiroz DMM, Barbosa AJA, et al. Campylobacter pyloridis in the upper gastrointestinal tract: A Brazilian study. Arq Gastroenterol 1987;24:5-9.
6. 6. Blaser MJ, Chyou PH, Nomura A. Age of establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer and duodenal ulcer risk. Cancer Res 1995;55:562-5.
7. 7. Correa P. Is gastric carcinoma an infectious disease? N Engl J Med 1991;325:1127-31.
8. 8. Goodwin CS. Gastric cancer and Helicobacter pylori: The whispering killer? Lancet 1993;342:507-8.
9. 9. Houben GMP, e Stochbrüger RW. Bacteria in the aetio-pathogenesis of gastric cancer: A review. Scand J Gastroenterol 1995;30 (suppl 212):13-8.
10. 10. Nomura A, Stemmermann GN, Chyou P, et al. Helicobacter pylori infection and gastric carcinoma in a population of Japanese-Americans in Hawaii. N Engl J Med 1991;325:1132-6.
11. 11. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
12. 12. Sipponen P, Hyvarinen H. Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand J Gastroenterol 1993;28 (suppl 196):3-6.
13. 13. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC Monographs on the evaluation of carcinogenic risks to humans. Lyon: IARC, 1994: Vol. 61.
14. 14. Blaser MJ. Hypotheses on pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 1992;102: 720-7.
15. 15. Blaser MJ. Intrastrain differences in Helicobacter pylori: A key question in mucosal damage? Ann Med 1995;27:559-63.
16. 16. McGuigan JE. Helicobacter pylori: The versatile pathogen. Dig Dis 1996;14:289-303.
17. 17. Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of 128-KDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90:5791-5.
18. 18. Leunk RD, Johnson PT, David BC, et al. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 1988;26: 93-9.
19. 19. Figura N, Bugnoli M, Cusi MG, et al. Pathogenic mechanisms of Helicobacter pylori: Production of cytotoxin. In: Helicobacter pylori, gastritis and peptic ulcer. Berlin Heidelberg: Springer-Verlag, 1990.
20. 20. Cover TL, Halter S, Blaser MJ. Characterization of HeLa cell vacuoles induced by Helicobacter pylori broth culture supernatant. Hum Pathol 1992;23:1004-10.
21. 21. Cover TL. The vacuolating cytotoxin of Helicobacter pylori. Molec Microbiol 1996;20:241-6.
22. 22. Ghiara P, Marchetti M, Blaser MJ, et al. Role of the virulence factors vacuolating cytotoxin, CagA and urease in a mouse model of disease. Infect Immun 1995;63:4154-60.
23. 23. De Koster E, Buset M, Fernandes E, et al. Influence of H. pylori and gastritis on gastric antrum and corpus mucosal cell proliferation status. Acta Gastro-Enterologica Belgica 1993;56 (suppl):61.
24. 24. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995; 19(suppl 1):s37-s43.
25. 25. Figura N, Guglielmetti P, Russolini A, et al. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcer and from patients with chronic gastritis only. J Clin Microbiol 1989; 27:225-6.
26. 26. Goossens H, Glupczynski Y, Burette A, et al. Role of the vacuolating toxin from Helicobacter pylori in the pathogenesis of duodenal and gastric ulcer. Med Microbiol Lett 1992;1:153-9.
27. 27. Tee W, Lambert JR, Dwyer B. Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases. J Clin Microbiol 1995;33:1203-5.
28. 28. Lage AP. New insights in the diagnosis and pathogenesis of Helicobacter pylori infection. Thesis for the achievement of Doctor of Science degree. Vrije Universiteit Brussel, Faculteit Wetenschappen, Brussels, Belgium, 1996.
29. 29. Fox JG, Correa P, Taylor NS, et al. High prevalence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis. Am J Gastroenterol 1992;87:1554-60.
30. 30. Hirai M, Azuma T, Ito S, et al. Prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric carcinoma patients. Int J Cancer 1994;56:56-60.
31. 31. Klaamas K, Held M, Wadström T, et al. IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int J Cancer 1996;67:1-5.
32. 32. Lage AP, Glupczynski Y, Burette A, et al. H. pylori vacuolating toxin and gastric cancer. Acta Gastro-Enterologica Belgica 1993;56(suppl):61.
33. 33. Murakita H, Hirai M, Ito S, et al. Vacuolating cytotoxin production by Helicobacter pylori isolates from peptic ulcer, atrophic gastritis and gastric carcinoma patients. Eur J Gastroenterol Hepatol 1994;6(suppl 1):S29-31.
34. 34. Queiroz DMM, Mendes EN, Rocha GA. An indicator medium for the isolation of Campylobacter pylori. J Clin Microbiol 1987;25:2378-9.
35. 35. Rocha GA, Queiroz DMM, Mendes EN, et al. Simple carbolfuchsin staining for showing C. pylori and other bacteria in gastric mucosa. J Clin Pathol 1989;42:1004-5.
36. 36. Rocha GA, Queiroz DMM, Oliveira AMR, et al. Serodiagnosis of H. pylori (HP) infection by a second generation ELISA test: Comparison between adults and children. Gut 1996;39(suppl 2):A121,4C:67.
37. 37. Laurén P. The two histological main types of gastric cancer: Diffuse and so-called intestinal type carcinoma. Acta Pathol Microbiol Scand 1965;64:31-49.
38. 38. Misiewicz JJ, Tytgat GNJ, Goodwin CS, et al. The Sydney System - a new classification of gastritis. World Congress of Gastroenterology, 9, Sydney, Australia, 1990 (Working Party Reports, 1-10).
39. 39. Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989;96(suppl):615-25.
40. 40. Mégraud F, Lamouliatte H. Helicobacter pylori and duodenal ulcer. Dig Dis Sci 1992;37:769-72.
41. 41. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. Br Med J 1991;302:1302-5.
42. 42. Blaser MJ, Parsonnet J. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994;94:4-8.
43. 43. Nomura A, Stermmermann GN, Chyou P, et al. Helicobacter pylori and the risk for duodenal and gastric ulceration. Ann Intern Med 1994;120:977-81.
44. 44. Azuma T, Konishi J, Tanaka Y, et al. Contribution of HLA-DQA gene to host's response against Helicobacter pylori. Lancet 1994;343: 542-3.
45. 45. Boren T, Falk P, et al. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993; 262:1892-5.
46. 46. Ricci V, Sommi P, Fiocca R, et al. Cytotoxicity of Helicobacter pylori on human gastric epithelial cells in vitro: Role of cytotoxin(s) and ammonia. Eur J Gastroenterol Hepatol 1993;5:687-94.
47. 47. Cover TL, Blaser M. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 1992;267:10570-5.
48. 48. Rautelin H, Blomberg B, Järnerot G, Danielsson D. Nonopsonic activation of neutrophils and cytotoxin production by Helicobacter pylori: Ulcerogenic markers. Scan J Gastroenterol 1994;29:128-32.
49. 49. Xiang Z, Cencini S, Bayeli P, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995;63:94-8.
50. 50. Crabtree JE, Taylor JD, Wyatt JI, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991;338:332-5.
51. 51. Atherton JC, Peek RM Jr, Tham K, et al. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 1997;112:92-9.
52. 52. Zhang QB, Nakshabendi IM, Mokhashi MS, et al. Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis. Gut 1996;38:841-5.